530057 — Vivanza Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Vivanza Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.551	1.41	1.67	1.17	0.653
Net Total Accounts Receivable
Net Total Receivables	97.7	166	132	97	151
Total Inventory
Total Other Current Assets
Total Current Assets	125	196	157	124	191
Net Property, Plant And Equipment	6.82	6.79	7.05	6.99	8.01
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	156	225	195	165	221
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	94.7	170	122	91.5	169
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	121	184	149	125	177
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	34.9	40.9	46.4	39.6	43.6
Total Liabilities & Shareholders' Equity	156	225	195	165	221
Total Common Shares Outstanding